Glimpses
BLEPHEX, LLC EXHIBITS FIRST MEDICAL DEVICE FOR PAINLESS,
IN OFFICE TREATMENT OF BLEPHARITIS AT AAO 2014
The first medical device that allows doctors to
perform a painless, in office procedure to treat
blepharitis, thus relieving patients from the
chronic and irritating symptoms of inflammatory
lid disease and dry eye, is being exhibited at AAO
2014, Chicago, announced by Dr. James Rynerson,
MD, Board Certified Ophthalmologist, and
president and CEO of BlephEx, LLC.
patients over 65, and up to 35 per cent of
all patients, have some form of blepharitis,
Dr. Rynerson noted. “In the same way that
gingivitis and tooth loss can be avoided by
regular teeth cleaning and flossing, blepharitis
and tear gland damage can be controlled by
BlephEx treatments every four to six months,
followed by nightly home maintenance. With
routine maintenance blepharitis symptoms
such as itching or scratchy eyes, foreign body
sensation, tearing, crusting, redness and
inflammation, mattering, dry eyes and eye
rubbing can be significantly reduced,” according to Dr. Rynerson. For more information
visit:www.BlephEx.com.
The BlephEx™ hand piece enables eye care
professionals to reduce scurf, bacterial debris and
the biofilm, thereby improving the overall health
of the eyelid, Dr. Rynerson said. BlephEx™ can
save patients hundreds of dollars in the costs of
prescription drops, home scrubs, humidity goggles
and artificial tears that mask the symptoms but
do not eliminate the cause. BlephEx removes
the biofilm, completely clearing the lids of the
inflammatory exotoxins that accumulate along
the margins, explained Dr. Rynerson.
BlephEx features a medical grade disposable,
micro-sponge that spins along the edge of eyelids
and lashes, exfoliating the eyelids. A numbing
drop is placed in each eye prior to treatment for
increased comfort. Following the six to eight
minute, well-tolerated procedure, patients often
report a near immediate resolution of the chronic
eye irritation associated with blepharitis and an
eventual resumption of normal tear production.
Studies show that more than 70 per cent of
Optical Prism | November-December 2014 35